Profiel
Mr. Jason G.
Duncan is a Chief Legal & Administrative Officer at Neumora Therapeutics, Inc. and a Software Engineer at American Panel Corp.
Mr. Duncan was previously employed as a General Counsel by Albireo Pharma, Inc., a General Counsel by Stallergenes Greer, Inc., a Vice President, Head-Compliance & Legal by Sobi, Inc., a Vice President, Head-Compliance & Legal by Swedish Orphan Biovitrum AB, and an Associate General Counsel by EMD Serono, Inc. He received his undergraduate degree from Dickinson College and a graduate degree from Suffolk University Law School.
Actieve functies van Jason G. Duncan
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Hoofd Administratief Officier | 12-12-2023 |
American Panel Corp.
American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Jason G. Duncan
| Bedrijven | Functie | Einde |
|---|---|---|
Stallergenes Greer, Inc.
Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | Algemeen Adviseur | 01-06-2018 |
Sobi, Inc.
Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Compliance Officer | 01-10-2015 |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01-08-2015 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01-07-2014 |
| ALBIREO PHARMA, INC. | Algemeen Adviseur | - |
Opleiding van Jason G. Duncan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Panel Corp.
American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems | Consumer Durables |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Suffolk University Law School
Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Stallergenes Greer, Inc.
Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | Health Technology |
Sobi, Inc.
Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Commercial Services |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
















